News

Tel Aviv, Israel.

NovellusDx abstract, titled “NovellusDx Functional Oncology Diagnostics” has been  accepted for oral presentation by the scientific committee of the MIXiii Biomed 2017 to be held in Tel Aviv, Israel on May 23, 2017 at 12:25 PM in a company presentation session in the upcoming conference program.

In addition, NovellusDx has been chosen by the Israel Innovation Authority and the BIOMED 2017 steering committee to participate in the Israel Innovation Authority startup pavilion. NovellusDx team will exhibit on day 2 of the event on 24.5 at booth number 5.